Delivery Order SPE2DB24D1205-SPE2DB25FCWDM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,813.50 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, a human chorionic gonadotropin medication. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pregnyl 10,000 Unit Vials, a human chorionic gonadotropin pharmaceutical product. This firm fixed-price delivery order, valued at $1,813.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,753.52 to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pregnyl 10,000 unit vials, with a ceiling value of $1,813.50. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,418.00 for 10,000 unit vials of Pregnyl on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price contract represents a non-set-aside award executed under AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,627.00 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with performance completed by July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,022.50 to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a $1,370.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Pregnyl 10,000 unit vials, with an ultimate completion date of September 4, 2025. This non-set-aside contract is a child order placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a $2,418 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pregnyl 10,000 Unit Vials with a ceiling value of $3,022.50. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWDMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,208.42 to AmerisourceBergen Drug Corp for 10,000-unit vials of Pregnyl, a human chorionic gonadotropin medication. The contract, awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC supports military healthcare programs globally by enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with a demonstrated track record of fulfilling competitive federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/24/25 |